TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32170961

Group type: EXPERIMENTAL
Intervention: hrHPV-positive women with positive high-grade squamous intraepithelial lesion (HSIL) cytology
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: hrHPV-positive women with positive low-grade squamous intraepithelial lesion (LSIL) cytology
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: hrHPV-positive women with positive atypical squamous cells of undetermined significance (ASC-US) cytology
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: hrHPV-positive women with p16 positive
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: Referral of women positive for either p16 or LSIL+ cytology
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: hrHPV-positive women negative for both p16 and cytology (LSIL threshold)
Number of subjects: 1091

Group type: EXPERIMENTAL
Intervention: hrHPV-positive women positive for either p16 or HPV16/33
Number of subjects: 1091
Study: 35091184

Group type: EXPERIMENTAL
Intervention: Neo‐adjuvant radiotherapy (NART) before NACT
Number of subjects: 20

Group type: COMPARATOR
Intervention: NACT and postoperative RT
Number of subjects: 20
Study: 33640376

Group type: EXPERIMENTAL
Intervention: Breakfast with a bitter espresso coffee and a whole wheat croissant
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Breakfast with a bitter espresso coffee and a protein croissant
Number of subjects: 40

Group type: COMPARATOR
Intervention: Whole wheat croissant
Number of subjects: 40

Group type: COMPARATOR
Intervention: Protein croissant
Number of subjects: 40
Study: 32622394

Group type: EXPERIMENTAL
Intervention: Ambulatory care (n=117)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Standard care (n=119)
Number of subjects: 236
Study: 35258240

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33268341

Group type: EXPERIMENTAL
Intervention: Tiotropium/olodaterol (T/O)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol (F/S)
Number of subjects: 76
Study: 36169918

Group type: EXPERIMENTAL
Intervention: Resveratrol and myoinositol (1000 mg each, twice daily for 12 weeks)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Metformin and pioglitazone (500 mg and 15 mg respectively, twice daily for 12 weeks)
Number of subjects: 110
Study: 34119717

Group type: COMPARATOR
Intervention: Standard Prolonged Exposure (SPE; 10 weekly 90-min sessions)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Massed Prolonged Exposure (MPE; 10 daily 90-min sessions)
Number of subjects: 135
Study: 32222015

Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 35393520

Group type: EXPERIMENTAL
Intervention: Peer group with a high proportion of parents believing boys are innately better than girls at learning mathematics
Number of subjects: 0
Study: 34698463

Group type: EXPERIMENTAL
Intervention: Xingnao Kaiqiao needling combined with respiratory training
Number of subjects: 124

Group type: COMPARATOR
Intervention: Respiratory training (control group)
Number of subjects: 124
Study: 34010418

Group type: EXPERIMENTAL
Intervention: Omission of axillary lymph node dissection
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Mastectomy without adjuvant radiotherapy
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Breast-conserving surgery
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Mastectomy
Number of subjects: 566
Study: 32191766

Group type: EXPERIMENTAL
Intervention: 1:2 dextrose solution (HYPO)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hartmann's solution (ISO)
Number of subjects: 40
Study: 33363447

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) with bioresorbable vascular scaffold (BVS) placement
Number of subjects: 34

Group type: COMPARATOR
Intervention: Optimal medicinal therapy (OMT)
Number of subjects: 34
Study: 35187941

Group type: EXPERIMENTAL
Intervention: Tele-exercises (TE) applied 3 days/week for 8 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Tele-exercises + Nutritional Coaching (TE+NC) applied 3 days/week for TE and 1 day/week for NC for 8 weeks
Number of subjects: 41
Study: 33409843

Group type: EXPERIMENTAL
Intervention: Hydrotherapy program based on McKenzie and Williams therapy, performed individually 3 days per week for 20 sessions.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 28
Study: 34279777

Group type: EXPERIMENTAL
Intervention: Classroom-centered intervention (CC)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Family school partnership (FSP) intervention
Number of subjects: 700

Group type: COMPARATOR
Intervention: Business as usual (control group)
Number of subjects: 700
Study: 34527335

Group type: EXPERIMENTAL
Intervention: New percutaneous positioning device combined with CNLB (n=75)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard CNLB (control, n=75)
Number of subjects: 150
Study: 32316794

Group type: EXPERIMENTAL
Intervention: White noise CD
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no white noise)
Number of subjects: 60
Study: 32087610

Group type: EXPERIMENTAL
Intervention: LifeStories video self-help intervention based on acceptance and commitment therapy (ACT), used over a period of 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Attention-matched comparison group (control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: LifeStories video self-help intervention based on acceptance and commitment therapy (ACT)
Number of subjects: 40
Study: 35979768

Group type: EXPERIMENTAL
Intervention: Cervical vertebra pulling therapy (once a week, 4 times total)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sitting traction therapy (once a week, 4 times total)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cervical vertebra pulling therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sitting traction therapy
Number of subjects: 60
Study: 33663253

Group type: EXPERIMENTAL
Intervention: Needle Guide (NG) technique
Number of subjects: 34

Group type: COMPARATOR
Intervention: Free Hand (FH) technique
Number of subjects: 34
Study: 32103635

Group type: EXPERIMENTAL
Intervention: Mindfulness programme delivered over 9 weeks by a Registered Nurse trained in mindfulness strategies.
Number of subjects: 140

Group type: COMPARATOR
Intervention: Routine care as provided in the facilities, including routine check-ups at diabetes clinics.
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Mindfulness programme
Number of subjects: 140
Study: 35181680

Group type: EXPERIMENTAL
Intervention: Salivary RT-LAMP assay
Number of subjects: 443

Group type: COMPARATOR
Intervention: Nasopharyngeal (NP) swabs tested by RT-qPCR
Number of subjects: 443
Study: 34311473

Group type: EXPERIMENTAL
Intervention: Deep Convolutional Neural Network (DCNN) using Med3D with data augmentation (DA) and global average pooling (GAP) techniques
Number of subjects: 159

Group type: COMPARATOR
Intervention: Native DCNN without data augmentation or global average pooling
Number of subjects: 159
Study: 35609488

Group type: EXPERIMENTAL
Intervention: μ‐Scan 2.0 automation system
Number of subjects: 1726

Group type: COMPARATOR
Intervention: Manual smear microscopy
Number of subjects: 1726
Study: 33074196

Group type: EXPERIMENTAL
Intervention: Phototherapy without head cover (Group A)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Phototherapy with head cover (Group B)
Number of subjects: 112
Study: 32151249

Group type: EXPERIMENTAL
Intervention: Statin prescription
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: High baseline low-density lipoprotein cholesterol
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Increasing duration of diabetes
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Presence of chronic kidney disease
Number of subjects: 500
Study: 36235868

Group type: EXPERIMENTAL
Intervention: Intermittent fasting (16 hours fasting per day for three months)
Number of subjects: 30
Study: 33770218

Group type: EXPERIMENTAL
Intervention: Diet based on the Dietary Guidelines for Americans (DGA 2010)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Typical American diet (TAD)
Number of subjects: 44
Study: 32081901

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (NMDA receptor antagonist)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 34404339

Group type: EXPERIMENTAL
Intervention: 50g xylitol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 75g erythritol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 75g glucose
Number of subjects: 20

Group type: COMPARATOR
Intervention: 300mL tap water
Number of subjects: 20
Study: 32023013

Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 268

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 268
Study: 33236240

Group type: COMPARATOR
Intervention: Group 1 (shorter root length)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Group 2 (longer root length)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Correlation between DZ level and root/tooth length
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Correlation between DZ thickness and distal groove depth
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Correlation between DZ position and depth of mesial grooves
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Correlation between DZ position and depth of distal grooves
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Correlation between root length and distal groove depth
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Correlation between orifice distance and mesial groove depth
Number of subjects: 28
Study: 33301079

Group type: EXPERIMENTAL
Intervention: Long-term vitamin D supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term n-3 fatty acid supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo or no supplementation)
Number of subjects: 0
Study: 34283004

Group type: EXPERIMENTAL
Intervention: 10-weeks of the online metacognitive intervention (MCI)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Wait-list (WL)
Number of subjects: 108
Study: 34797294

Group type: EXPERIMENTAL
Intervention: Acupuncture, 2 times a week for 12 weeks (total of 24 sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham acupuncture, 2 times a week for 12 weeks (total of 24 sessions)
Number of subjects: 50
Study: 35339324

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 78
Study: 33333146

Group type: EXPERIMENTAL
Intervention: High-intensity running exercise under hypoxia (fraction of inspired oxygen 14.5%)
Number of subjects: 21

Group type: COMPARATOR
Intervention: High-intensity running exercise under normoxia (fraction of inspired oxygen 20.9%)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Echocardiography during stress
Number of subjects: 21

Group type: COMPARATOR
Intervention: Echocardiography under hypoxia
Number of subjects: 21
Study: 33954911

Group type: EXPERIMENTAL
Intervention: 6 mg dexamethasone phosphate (DEX-P)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 6 mg betamethasone phosphate (BET-P)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 1:1 mixture of betamethasone phosphate and acetate (BET-PA)
Number of subjects: 48
Study: 32236718

Group type: EXPERIMENTAL
Intervention: Concomitant antiplatelet therapy (APT)
Number of subjects: 2199

Group type: COMPARATOR
Intervention: No concomitant antiplatelet therapy (APT)
Number of subjects: 2199
Study: 35414108

Group type: EXPERIMENTAL
Intervention: Double injection (DI) of local anesthetics (0.5% ropivacaine 24 mL)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Triple injection (TI) of local anesthetics (0.5% ropivacaine 24 mL)
Number of subjects: 86
Study: 34792926

Group type: EXPERIMENTAL
Intervention: Education and counseling program on preeclampsia
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard prenatal care
Number of subjects: 132
Study: 33390056

Group type: COMPARATOR
Intervention: Methotrexate (Mtx)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Methotrexate plus intramuscular vitamin D (MtxD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (Methotrexate alone)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Control group (Methotrexate plus vitamin D)
Number of subjects: 30
Study: 33340522

Group type: EXPERIMENTAL
Intervention: Oxytocin (40 IU)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Higher anti-dopaminergic medication dosage
Number of subjects: 26
Study: 35099998

Group type: EXPERIMENTAL
Intervention: Outpatient therapy without antibiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antibiotics
Number of subjects: 0
Study: 34931999

Group type: EXPERIMENTAL
Intervention: e‐cigarettes are as harmful or more harmful than smoking
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: e‐cigarettes are completely harmless
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Uncertainty about e‐cigarette harms
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Control (physical activity)
Number of subjects: 2400
Study: 36293136

Group type: EXPERIMENTAL
Intervention: Microencapsulated ferric saccharate (MFS) 60 mg/day for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ferrous sulphate (FS) 60 mg/day for 14 days
Number of subjects: 0
Study: 34172613

Group type: EXPERIMENTAL
Intervention: LPS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 36380013

Group type: EXPERIMENTAL
Intervention: Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
Number of subjects: 380
Study: 32985145

Group type: EXPERIMENTAL
Intervention: New Pulse Shape 1 (NPS1)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: New Pulse Shape 2 (NPS2)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Standard Pulse Shape (SPS)
Number of subjects: 145
Study: 35891482

Group type: EXPERIMENTAL
Intervention: WEVEE VRP vaccine (two doses, administered 28 days apart)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (11 NHPs)
Number of subjects: 33
Study: 33975865

Group type: EXPERIMENTAL
Intervention: Prescription sleep medications
Number of subjects: 238

Group type: COMPARATOR
Intervention: Non-users of prescription sleep medications
Number of subjects: 238
Study: 32371767

Group type: EXPERIMENTAL
Intervention: Intensive SBP goal of less than 120mmHg
Number of subjects: 5385
Study: 36401416

Group type: EXPERIMENTAL
Intervention: Trocar needle
Number of subjects: 503

Group type: COMPARATOR
Intervention: Steel needle
Number of subjects: 503
Study: 35879528

Group type: EXPERIMENTAL
Intervention: Palaeolithic diet
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control low‐fat diet
Number of subjects: 70
Study: 34747368

Group type: EXPERIMENTAL
Intervention: Tocilizumab (7 monthly doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32132641

Group type: EXPERIMENTAL
Intervention: Reduced bedtime variability (n=29)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Increased/maintained bedtime variability (n=8)
Number of subjects: 37
Study: 36605335

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-PRP
Number of subjects: 20
Study: 33037681

Group type: EXPERIMENTAL
Intervention: 15-minute infusion of vincristine (VCR)
Number of subjects: 429

Group type: COMPARATOR
Intervention: 3-hour infusion of vincristine (VCR)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Intracellular VCR24h levels in B-ALL patients
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: ABCB1 genotype 2677GG
Number of subjects: 429
Study: 32544361

Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 1st interval of 28–40 d and a 2nd interval of 140–160 d
Number of subjects: 3689

Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 1st interval of 41–50 d
Number of subjects: 3689

Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 1st interval of 51–60 d
Number of subjects: 3689

Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 2nd interval of 103–139 d
Number of subjects: 3689

Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 2nd interval of 140–160 d
Number of subjects: 3689

Group type: EXPERIMENTAL
Intervention: bivalent HPV‐16/18 vaccine with a 2nd interval of 161–198 d
Number of subjects: 3689
Study: 33466879

Group type: EXPERIMENTAL
Intervention: Decision aids used in TKR surgery
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Decision aids
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Qualitative studies
Number of subjects: 17
Study: 35262615

Group type: EXPERIMENTAL
Intervention: Volumes 2 and 3 recommendations
Number of subjects: 409

Group type: COMPARATOR
Intervention: Volume 1 recommendations (control)
Number of subjects: 409
Study: 32145041

Group type: EXPERIMENTAL
Intervention: morphine-naloxone 100:1 (75 mg: 0.75 mg)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: morphine-naloxone 200:1 (75 mg: 0.375 mg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: morphine mono (75 mg)
Number of subjects: 43
Study: 34928306

Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 2682

Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 2682

Group type: COMPARATOR
Intervention: Erenumab (both doses)
Number of subjects: 2682
Study: 34908832

Group type: EXPERIMENTAL
Intervention: Tiotropium/Olodaterol
Number of subjects: 69

Group type: COMPARATOR
Intervention: Tiotropium
Number of subjects: 69
Study: 33279603

Group type: EXPERIMENTAL
Intervention: Enteric-coated fast release formulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TS1 system (time scale factor between Tvitro and Tvivo equals to 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IVIVC model
Number of subjects: 0
Study: 32414548

Group type: EXPERIMENTAL
Intervention: 3dMDface scanning system (3dMD Inc, Atlanta, Ga)
Number of subjects: 279
Study: 35912151

Group type: EXPERIMENTAL
Intervention: HbA1c = 7% group
Number of subjects: 233

Group type: COMPARATOR
Intervention: HbA1c > 7% group
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: HbA1c level
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 233
Study: 33058774

Group type: EXPERIMENTAL
Intervention: Intravenous (IV) dexamethasone
Number of subjects: 130

Group type: COMPARATOR
Intervention: Submucosal (SM) dexamethasone
Number of subjects: 130
Study: 35380237

Group type: EXPERIMENTAL
Intervention: Responsive (RG, n = 15)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Controlled Crying (CCG, n = 18)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Control (Treatment as Usual, TAUG, n = 8)
Number of subjects: 199
Study: 33620762

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 32596755

Group type: EXPERIMENTAL
Intervention: Twisted wire splint (0.0175 stainless steel twisted wire)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Ribbon wire (single-strand ribbon titanium wire)
Number of subjects: 260
Study: 36056407

Group type: COMPARATOR
Intervention: Service as usual (SAU) alone
Number of subjects: 284
Study: 33834913

Group type: EXPERIMENTAL
Intervention: Modified Atkins diet
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (no diet)
Number of subjects: 91
Study: 32212354

Group type: EXPERIMENTAL
Intervention: Parenteral Nutrition (PN)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Oral Feeding (OF)
Number of subjects: 148
Study: 35151260

Group type: EXPERIMENTAL
Intervention: Breastfeeding in public (image of a woman breastfeeding)
Number of subjects: 506

Group type: COMPARATOR
Intervention: Non-breastfeeding (image of a woman not breastfeeding)
Number of subjects: 506
Study: 34077509

Group type: EXPERIMENTAL
Intervention: Risankizumab 180 mg every 8 weeks
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Risankizumab 600 mg every 4 weeks (for reinduction of four patients)
Number of subjects: 65
Study: 32063347

Group type: EXPERIMENTAL
Intervention: Construct #4 (4-core suture type configuration)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Construct #4 (4-core type repair)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Constructs #2, #3, and #4 (with Krackow locking sutures)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Construct #2
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Construct #3
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Construct #4
Number of subjects: 60
Study: 34920425

Group type: EXPERIMENTAL
Intervention: Artificial disc replacement (ADR)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Fusion surgery
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: MRI assessment of adjacent-segment pathology (ASP)
Number of subjects: 143
Study: 36287638

Group type: EXPERIMENTAL
Intervention: Time lapse system (TLS)
Number of subjects: 585

Group type: COMPARATOR
Intervention: Standard benchtop incubator
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: ICSI fertilized embryos
Number of subjects: 585

Group type: COMPARATOR
Intervention: Conventional IVF fertilized embryos
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Time lapse system (TLS) and Standard benchtop incubator
Number of subjects: 585
Study: 33670454

Group type: EXPERIMENTAL
Intervention: Health-Awareness-Strengthening Lifestyle (HASL) program
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (passive request for HASL program after post-test)
Number of subjects: 92
Study: 34125259

Group type: EXPERIMENTAL
Intervention: i-gel laryngeal mask airway
Number of subjects: 160

Group type: COMPARATOR
Intervention: classic laryngeal mask airway (LMA)
Number of subjects: 160

Group type: COMPARATOR
Intervention: laryngeal tube (LT)
Number of subjects: 160
Study: 34781362

Group type: EXPERIMENTAL
Intervention: CloFluBu conditioning regimen
Number of subjects: 155
Study: 32271354

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus docetaxel
Number of subjects: 78

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 78
Study: 35514364

Group type: EXPERIMENTAL
Intervention: Home-based NMES therapy
Number of subjects: 156

Group type: COMPARATOR
Intervention: Sham low-voltage NMES group
Number of subjects: 156
Study: 34956568

Group type: EXPERIMENTAL
Intervention: All-round care on the basis of conventional care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 60